SCHEMBL7026346

SCHEMBL7026346

ClCCCSCc1ccco1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 14/20 0.50
▸ MAPT P10636 6/20 0.50
▸ POLB P06746 6/20 0.50
▸ TDP1 Q9NUW8 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPC1 O15118 3/20 0.45
▸ RAB9A P51151 3/20 0.45
▸ USP2 O75604 2/20 0.45
▸ LMNA P02545 2/20 0.45
▸ RECQL P46063 2/20 0.45
▸ HPGD P15428 4/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ CHRM2 P08172 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ KMT2A Q03164 4/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ ALOX12 P18054 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10685820 0.89 ALDH1A1 (0.53) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL25278960 0.81 ALDH1A1 (0.50) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL423623 0.81 ALDH1A1 (0.54) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL9697427 0.80 — —
SCHEMBL140950 0.80 TSHR (0.59) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL4869503 0.79 ALDH1A1 (0.54) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL21654312 0.77 ALDH1A1 (0.50) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL10543352 0.77 ALDH1A1 (0.47) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL6130008 0.77 ALDH1A1 (0.57) ALDH1A1MAPTPOLBTDP1SMN1; SMN2
SCHEMBL705421 0.77 ALDH1A1 (0.53) ALDH1A1MAPTPOLBTDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0920441-B1 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENT SCHERING AG (DE) 2003-01-29 — — EP disclosed
US-6271403-B1 PURE ANTIESTROGENS, OR ESTROGENIC ANTIESTROGENS WITH ESTROGENIC PARTIAL ACTION. SCHERING AKTIENGESELLSCHAFT (DE) 2001-08-07 — — US disclosed
US-5986115-A STEROIDS WITH FLUORO GROUPS AND ETHER OR ESTER GROUPS SCHERING AG (DE) 1999-11-16 — — US disclosed
EP-0920441-A1 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENT SCHERING AKTIENGESELLSCHAFT (DE) 1999-06-09 — — EP disclosed
US-5866560-A ESTROGEN INHIBITORS; TUMOR THERAPY; HORMONE REPLACEMENT THERAPY SCHERING AG (DE) 1999-02-02 — — US disclosed
WO-1998007740-A1 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 1998-02-26 — — WO disclosed
Send feedback